{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T23:38:33Z","timestamp":1791243513089,"version":"4.1.0"},"reference-count":169,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Angiotensin-converting enzyme (ACE), a zinc metalloprotein, is a central component of the renin\u2013angiotensin system (RAS). It degrades bradykinin and other vasoactive peptides. Angiotensin-converting-enzyme inhibitors (ACE inhibitors, ACEIs) decrease the formation of angiotensin II and increase the level of bradykinin, thus relaxing blood vessels as well as reducing blood volume, lowering blood pressure and reducing oxygen consumption by the heart, which can be used to prevent and treat cardiovascular diseases and kidney diseases. Nevertheless, ACEIs are associated with a range of adverse effects such as renal insufficiency, which limits their use. In recent years, researchers have attempted to reduce the adverse effects of ACEIs by improving the selectivity of ACEIs for structural domains based on conformational relationships, and have developed a series of novel ACEIs. In this review, we have summarized the research advances of ACE inhibitors, focusing on the development sources, design strategies and analysis of structure-activity relationships and the biological activities of ACE inhibitors.<\/jats:p>","DOI":"10.3389\/fphar.2022.968104","type":"journal-article","created":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T07:03:40Z","timestamp":1667286220000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":71,"title":["Small molecule angiotensin converting enzyme inhibitors: A medicinal chemistry perspective"],"prefix":"10.3389","volume":"13","author":[{"given":"Wenyue","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erkang","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changhan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keyue","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changyu","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,11,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1038\/nrd1227","article-title":"Ace revisited: A new target for structure-based drug design","volume":"2","author":"Acharya","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"key":"B2","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.jmb.2010.05.024","article-title":"High-resolution crystal structures of Drosophila melanogaster angiotensin-converting enzyme in complex with novel inhibitors and antihypertensive drugs","volume":"400","author":"Akif","year":"2010","journal-title":"J. Mol. Biol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"4525","DOI":"10.1111\/febs.12038","article-title":"Structural basis of peptide recognition by the angiotensin-1 converting enzyme homologue AnCE from Drosophila melanogaster","volume":"279","author":"Akif","year":"2012","journal-title":"FEBS J."},{"key":"B4","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1042\/BJ20102123","article-title":"Novel mechanism of inhibition of human angiotensin-I-converting enzyme (ACE) by a highly specific phosphinic tripeptide","volume":"436","author":"Akif","year":"2011","journal-title":"Biochem. J."},{"key":"B5","doi-asserted-by":"publisher","first-page":"11832","DOI":"10.1021\/jf404641v","article-title":"Angiotensin-converting enzyme inhibitory effects by plant phenolic compounds: A study of structure activity relationships","volume":"61","author":"Al Shukor","year":"2013","journal-title":"J. Agric. Food Chem."},{"key":"B6","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1177\/106002809603000110","article-title":"Adverse effects of the angiotensin-converting enzyme inhibitors","volume":"30","author":"Alderman","year":"1996","journal-title":"Ann. Pharmacother."},{"key":"B7","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.foodres.2013.08.027","article-title":"Identification of ace-inhibitory peptides from squid skin collagen after in vitro gastrointestinal digestion","volume":"54","author":"Alem\u00e1n","year":"2013","journal-title":"Food Res. Int."},{"key":"B8","doi-asserted-by":"publisher","first-page":"5435","DOI":"10.2147\/IJN.S203311","article-title":"Self-nanoemulsifying ramipril tablets: A novel delivery system for the enhancement of drug dissolution and stability","volume":"14","author":"Alhasani","year":"2019","journal-title":"Int. J. Nanomedicine"},{"key":"B9","doi-asserted-by":"crossref","DOI":"10.1002\/9783527805921","volume-title":"Natural products targeting clinically relevant enzymes","author":"Andrade","year":"2017"},{"key":"B10","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.ahj.2020.01.003","article-title":"Long-term clinical outcomes with use of an angiotensin-converting enzyme inhibitor early after heart transplantation","volume":"222","author":"Arashi","year":"2020","journal-title":"Am. Heart J."},{"key":"B11","doi-asserted-by":"publisher","first-page":"3371","DOI":"10.1021\/acs.jmedchem.1c01924","article-title":"Probing the requirements for dual angiotensin-converting enzyme C-domain selective\/neprilysin inhibition","volume":"65","author":"Arendse","year":"2022","journal-title":"J. Med. Chem."},{"key":"B12","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.jfda.2015.11.010","article-title":"Biochemical characterization of a novel antioxidant and angiotensin I-converting enzyme inhibitory peptide from Struthio camelus egg white protein hydrolysis","volume":"24","author":"Asoodeh","year":"2016","journal-title":"J. Food Drug Anal."},{"key":"B13","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.foodchem.2013.03.091","article-title":"Nine novel angiotensin I-converting enzyme (ACE) inhibitory peptides from cuttlefish (Sepia officinalis) muscle protein hydrolysates and antihypertensive effect of the potent active peptide in spontaneously hypertensive rats","volume":"170","author":"Balti","year":"2015","journal-title":"Food Chem."},{"key":"B14","doi-asserted-by":"publisher","first-page":"s42","DOI":"10.1007\/s00592-005-0180-4","article-title":"Preventing renal complications in diabetic patients: The diabetics exposed to telmisartan and enalaprIL (DETAIL) study","volume":"42","author":"Barnett","year":"2005","journal-title":"Acta Diabetol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"4371","DOI":"10.1111\/bph.14495","article-title":"Reversal of albuminuria by combined AM6545 and perindopril therapy in experimental diabetic nephropathy: AM6545 and perindopril reverse albuminuria in diabetic mice","volume":"175","author":"Barutta","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1124\/pr.112.006809","article-title":"A modern understanding of the traditional and nontraditional biological functions of angiotensin-converting enzyme","volume":"65","author":"Bernstein","year":"2013","journal-title":"Pharmacol. Rev."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1515\/hsz-2012-0170","article-title":"Characterization of angiotensin I-converting enzyme N-domain selectivity using positional-scanning combinatorial libraries of fluorescence resonance energy transfer peptides","volume":"393","author":"Bersanetti","year":"2012","journal-title":"Biol. Chem."},{"key":"B18","doi-asserted-by":"publisher","first-page":"835136","DOI":"10.3389\/fphar.2022.835136","article-title":"Pharmacogenetics and precision medicine approaches for the improvement of COVID-19 therapies","volume":"13","author":"Biswas","year":"2022","journal-title":"Front. Pharmacol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1007\/s00259-020-04736-8","article-title":"Angiotensin-converting enzyme inhibitor treatment early after myocardial infarction attenuates acute cardiac and neuroinflammation without effect on chronic neuroinflammation","volume":"47","author":"Borchert","year":"2020","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"B20","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1161\/HYPERTENSIONAHA.112.196352","article-title":"Pregnancy outcome following exposure to angiotensin-converting enzyme inhibitors or angiotensin receptor antagonists: A systematic review","volume":"60","author":"Bullo","year":"2012","journal-title":"Hypertension"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1007\/s00467-004-1516-y","article-title":"Two different therapeutic regimes in patients with sequelae of hemolytic-uremic syndrome","volume":"19","author":"Caletti","year":"2004","journal-title":"Pediatr. Nephrol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1097\/00004872-200410000-00020","article-title":"Evidence against a major role for angiotensin converting enzyme-related carboxypeptidase (ACE2) in angiotensin peptide metabolism in the human coronary circulation","volume":"22","author":"Campbell","year":"2004","journal-title":"J. Hypertens."},{"key":"B23","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.joim.2021.09.006","article-title":"Angiotensin-converting enzyme inhibitors from plants: A review of their diversity, modes of action, prospects, and concerns in the management of diabetes-centric complications","volume":"19","author":"Chakraborty","year":"2021","journal-title":"J. Integr. Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"2516","DOI":"10.1038\/ncomms3516","article-title":"Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels","volume":"4","author":"Chauhan","year":"2013","journal-title":"Nat. Commun."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1021\/acs.chemrev.8b00201","article-title":"Targeting metalloenzymes for therapeutic intervention","volume":"119","author":"Chen","year":"2019","journal-title":"Chem. Rev."},{"key":"B26","doi-asserted-by":"publisher","first-page":"5473","DOI":"10.1021\/bi700275e","article-title":"The structure of testis angiotensin-converting enzyme in complex with the C domain-specific inhibitor RXPA380","volume":"46","author":"Corradi","year":"2007","journal-title":"Biochemistry"},{"key":"B27","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/j.jmb.2006.01.048","article-title":"Crystal structure of the N domain of human somatic angiotensin I-converting enzyme provides a structural basis for domain-specific inhibitor design","volume":"357","author":"Corradi","year":"2006","journal-title":"J. Mol. Biol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"10141","DOI":"10.1021\/acs.jmedchem.8b01309","article-title":"Molecular basis for multiple omapatrilat binding sites within the ACE C-domain: Implications for drug design","volume":"61","author":"Cozier","year":"","journal-title":"J. Med. Chem."},{"key":"B29","doi-asserted-by":"publisher","first-page":"16543","DOI":"10.1111\/febs.16543","article-title":"Structural basis for the inhibition of human angiotensin\u20101 converting enzyme by fosinoprilat","author":"Cozier","year":"2022","journal-title":"FEBS J."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1111\/febs.14421","article-title":"Crystal structures of sampatrilat and sampatrilat-asp in complex with human ACE \u2013 A molecular basis for domain selectivity","volume":"285","author":"Cozier","year":"","journal-title":"FEBS J."},{"key":"B31","doi-asserted-by":"publisher","first-page":"2825","DOI":"10.1681\/ASN.2017060612","article-title":"Podocyte growing pains in adaptive FSGS","volume":"28","author":"D\u2019Agati","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"E316","DOI":"10.3390\/nu9040316","article-title":"Angiotensin-I-Converting enzyme (ACE)-Inhibitory peptides from plants","volume":"9","author":"Daskaya-Dikmen","year":"2017","journal-title":"Nutrients"},{"key":"B33","doi-asserted-by":"publisher","first-page":"169S","DOI":"10.1378\/chest.129.1_suppl.169S","article-title":"Angiotensin-converting enzyme inhibitor-induced cough: ACCP evidence-based clinical practice guidelines","volume":"129","author":"Dicpinigaitis","year":"2006","journal-title":"Chest"},{"key":"B34","doi-asserted-by":"publisher","first-page":"111","DOI":"10.3109\/09637486.2016.1144722","article-title":"Digestion and absorption of an egg white ACE-inhibitory peptide in human intestinal Caco-2 cell monolayers","volume":"67","author":"Ding","year":"2016","journal-title":"Int. J. Food Sci. Nutr."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1093\/ajh\/hpt090","article-title":"Ramipril-Induced liver injury: Case report and review of the literature","volume":"26","author":"Douros","year":"2013","journal-title":"Am. J. Hypertens."},{"key":"B36","first-page":"531","article-title":"Prominent features of allergic angioedema on oral mucosa","volume":"50","author":"Duvan\u010di\u0107","year":"2011","journal-title":"Acta Clin. Croat."},{"key":"B37","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1111\/j.1751-7176.2007.tb00005.x","article-title":"Combination therapy with an angiotensin-converting enzyme inhibitor and a calcium channel blocker","volume":"9","author":"Egan","year":"2007","journal-title":"J. Clin. Hypertens."},{"key":"B38","volume-title":"Angiotensin-converting enzyme: Zinc- and inhibitor-binding stoichiometries of the somatic and testis isozymes","author":"Ehlers","year":"2002"},{"key":"B39","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1593\/tlo.13346","article-title":"Exposure to ACEI\/ARB and \u03b2-blockers is associated with improved survival and decreased tumor progression and hospitalizations in patients with advanced colon cancer","volume":"6","author":"Engineer","year":"2013","journal-title":"Transl. Oncol."},{"key":"B40","first-page":"57","article-title":"Ramipril in post-renal transplant erythrocytosis","volume":"20","author":"Esposito","year":"2007","journal-title":"J. Nephrol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1016\/j.jacc.2016.01.050","article-title":"Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in myocardial infarction patients with renal dysfunction","volume":"67","author":"Evans","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1056\/NEJMoa053107","article-title":"Efficacy and safety of benazepril for advanced chronic renal insufficiency","volume":"10","author":"Fan","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"B43","doi-asserted-by":"publisher","first-page":"7147","DOI":"10.1021\/acs.jafc.9b01071","article-title":"Identification and characterization of gastrointestinal-resistant angiotensin-converting enzyme inhibitory peptides from egg white proteins","volume":"67","author":"Fan","year":"2019","journal-title":"J. Agric. Food Chem."},{"key":"B44","doi-asserted-by":"publisher","first-page":"2832","DOI":"10.1016\/j.jacc.2017.03.598","article-title":"Angiotensin-converting enzyme inhibition early after heart transplantation","volume":"69","author":"Fearon","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"4998","DOI":"10.1074\/jbc.M009009200","article-title":"Angiotensin I-converting enzyme transition state stabilization by His1089: Evidence for a catalytic mechanism distinct from other gluzincin metalloproteinases","volume":"276","author":"Fernandez","year":"2001","journal-title":"J. Biol. Chem."},{"key":"B46","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1021\/acs.jmedchem.7b01478","article-title":"The design and development of a potent and selective novel diprolyl derivative that binds to the N-domain of angiotensin-I converting enzyme","volume":"61","author":"Fienberg","year":"2018","journal-title":"J. Med. Chem."},{"key":"B47","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1017\/neu.2021.32","article-title":"Impact of ACE2 genetic variant on antidepressant efficacy of SSRIs","volume":"34","author":"Firouzabadi","year":"2022","journal-title":"Acta Neuropsychiatr."},{"key":"B48","doi-asserted-by":"publisher","first-page":"e650","DOI":"10.1210\/clinem\/dgaa718","article-title":"Angiotensin-converting enzyme inhibitors reduce uterine fibroid incidence in hypertensive women","volume":"106","author":"Fischer","year":"2021","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1001\/archinte.144.7.1441","article-title":"Review of the overall experience of captopril in hypertension","volume":"144","author":"Frohlich","year":"1984","journal-title":"Arch. Intern. Med."},{"key":"B50","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.foodres.2016.08.037","article-title":"Angiotensin I\u2013converting enzyme\u2013inhibitory peptides from bovine collagen: Insights into inhibitory mechanism and transepithelial transport","volume":"89","author":"Fu","year":"2016","journal-title":"Food Res. Int."},{"key":"B51","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1161\/HYPERTENSIONAHA.107.097865","article-title":"Angiotensin-converting enzyme C-terminal catalytic domain is the main site of angiotensin I cleavage in vivo","volume":"51","author":"Fuchs","year":"2008","journal-title":"Hypertension"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1681\/ASN.2012030271","article-title":"Growth-dependent podocyte failure causes glomerulosclerosis","volume":"23","author":"Fukuda","year":"2012","journal-title":"J. Am. Soc. Nephrol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.pharmthera.2008.02.007","article-title":"Role of bone marrow renin-angiotensin system in the pathogenesis of atherosclerosis","volume":"118","author":"Fukuda","year":"2008","journal-title":"Pharmacol. Ther."},{"key":"B54","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1002\/bip.20163","article-title":"Solid-phase synthesis and conformational properties of angiotensin converting enzyme catalytic-site peptides: The basis for a structural study on the enzyme-substrate interaction","volume":"76","author":"Galanis","year":"2004","journal-title":"Biopolymers"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1016\/j.foodchem.2011.06.051","article-title":"Purification and identification of ACE inhibitory peptides from Haruan (Channa striatus) myofibrillar protein hydrolysate using HPLC\u2013ESI-TOF MS\/MS","volume":"129","author":"Ghassem","year":"2011","journal-title":"Food Chem."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1016\/j.foodres.2011.04.006","article-title":"Angiotensin I-converting enzyme inhibitory activity of low-molecular-weight peptides from Atlantic salmon (Salmo salar L.) skin","volume":"44","author":"Gu","year":"2011","journal-title":"Food Res. Int."},{"key":"B57","doi-asserted-by":"publisher","first-page":"961","DOI":"10.3168\/jds.2018-14899","article-title":"Production and transepithelial transportation of angiotensin-I-converting enzyme (ACE)-inhibitory peptides from whey protein hydrolyzed by immobilized Lactobacillus helveticus proteinase","volume":"102","author":"Guo","year":"2019","journal-title":"J. Dairy Sci."},{"key":"B58","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/hr.2009.184","article-title":"Reinventing the ACE inhibitors: Some old and new implications of ACE inhibition","volume":"33","author":"Hanif","year":"2010","journal-title":"Hypertens. Res."},{"key":"B59","first-page":"5","article-title":"Comparative bioavailability study of two imidapril tablet formulations in Indonesian healthy subjects","volume":"12","author":"Harahap","year":"2021","journal-title":"Syst. Rev. Pharm."},{"key":"B60","doi-asserted-by":"publisher","first-page":"CD003823","DOI":"10.1002\/14651858.CD003823.pub2","article-title":"Blood pressure lowering efficacy of angiotensin converting enzyme (ACE) inhibitors for primary hypertension","volume":"2008","author":"Heran","year":"2008","journal-title":"Cochrane Database Syst. Rev."},{"key":"B61","unstructured":"Angiotensin converting enzyme inhibitors (ACEI)\n            HermanL. L.\n            PadalaS. A.\n            AhmedI.\n            BashirK.\n          2021"},{"key":"B62","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1253\/circj.69.671","article-title":"Angiotensin-converting enzyme inhibitor therapy inhibits the progression from paroxysmal atrial fibrillation to chronic atrial fibrillation","volume":"69","author":"Hirayama","year":"2005","journal-title":"Circ. J."},{"key":"B63","doi-asserted-by":"publisher","first-page":"e3721","DOI":"10.1097\/MD.0000000000003721","article-title":"Angiotensin-receptor blocker, angiotensin-converting enzyme inhibitor, and risks of atrial fibrillation: A nationwide cohort study","volume":"95","author":"Hsieh","year":"2016","journal-title":"Med. Baltim."},{"key":"B64","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/clpt.1991.54","article-title":"Pharmacokinetics of fosinopril in patients with various degrees of renal function","volume":"49","author":"Hui","year":"1991","journal-title":"Clin. Pharmacol. Ther."},{"key":"B65","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jare.2016.12.002","article-title":"Novel angiotensin-converting enzyme inhibitory peptides from caseins and whey proteins of goat milk","volume":"8","author":"Ibrahim","year":"2017","journal-title":"J. Adv. Res."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1016\/j.jff.2013.09.006","article-title":"Isolation of antioxidative and ACE inhibitory peptides from protein hydrolysate of skipjack (Katsuwana pelamis) roe","volume":"5","author":"Intarasirisawat","year":"2013","journal-title":"J. Funct. Foods"},{"key":"B67","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1111\/1541-4337.12051","article-title":"Food-originating ACE inhibitors, including antihypertensive peptides, as preventive food components in blood pressure reduction","volume":"13","author":"Iwaniak","year":"2014","journal-title":"Compr. Rev. Food Sci. Food Saf."},{"key":"B68","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1001\/jama.2013.284427","article-title":"2014 evidence-based guideline for the management of high blood pressure in adults: Report from the panel members appointed to the eighth joint national committee (JNC 8)","volume":"311","author":"James","year":"2014","journal-title":"JAMA"},{"key":"B69","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.biomed.2012.06.005","article-title":"Angiotensin I-converting enzyme inhibitory peptides: Inhibition mode, bioavailability, and antihypertensive effects","volume":"2","author":"Jao","year":"2012","journal-title":"BioMedicine"},{"key":"B70","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1007\/s11418-017-1095-4","article-title":"Phytochemical profile and angiotensin I converting enzyme (ACE) inhibitory activity of Limonium michelsonii Lincz","volume":"71","author":"Jenis","year":"2017","journal-title":"J. Nat. Med."},{"key":"B71","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/s41440-020-0455-8","article-title":"Interactions of coronaviruses with ACE2, angiotensin II, and RAS inhibitors-lessons from available evidence and insights into COVID-19","volume":"43","author":"Kai","year":"2020","journal-title":"Hypertens. Res."},{"key":"B72","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.cca.2021.10.029","article-title":"Angiotensin converting enzyme (ACE)","volume":"524","author":"Khurana","year":"2022","journal-title":"Clin. Chim. Acta."},{"key":"B73","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.procbio.2016.01.009","article-title":"Angiotensin I-converting enzyme inhibitory peptides from an enzymatic hydrolysate of flounder fish ( Paralichthys olivaceus ) muscle as a potent anti-hypertensive agent","volume":"51","author":"Ko","year":"2016","journal-title":"Process Biochem."},{"key":"B74","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1016\/j.procbio.2012.07.015","article-title":"A novel angiotensin I-converting enzyme (ACE) inhibitory peptide from a marine Chlorella ellipsoidea and its antihypertensive effect in spontaneously hypertensive rats","volume":"47","author":"Ko","year":"2012","journal-title":"Process Biochem."},{"key":"B75","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s11906-018-0859-x","article-title":"ACE inhibitor-induced angioedema: A review","volume":"20","author":"Kostis","year":"2018","journal-title":"Curr. Hypertens. Rep."},{"key":"B76","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1021\/ml4004588","article-title":"Interkingdom pharmacology of angiotensin-I converting enzyme inhibitor phosphonates produced by actinomycetes","volume":"5","author":"Kramer","year":"2014","journal-title":"ACS Med. Chem. Lett."},{"key":"B77","doi-asserted-by":"publisher","first-page":"8405","DOI":"10.1021\/bi9011226","article-title":"Investigating the domain specificity of phosphinic inhibitors RXPA380 and RXP407 in angiotensin-converting enzyme","volume":"48","author":"Kr\u00f6ger","year":"2009","journal-title":"Biochemistry"},{"key":"B78","doi-asserted-by":"publisher","first-page":"A75","DOI":"10.1253\/circj.71.a75","article-title":"Upstream therapy for atrial fibrillation","volume":"71","author":"Kumagai","year":"2007","journal-title":"Circ. J."},{"key":"B79","first-page":"388","article-title":"Modern development in ACE inhibitors","volume":"2","author":"Kumar","year":"2010","journal-title":"Lettre, Der Pharmacia"},{"key":"B80","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.foodchem.2015.02.004","article-title":"Rapid purification and characterization of angiotensin converting enzyme inhibitory peptides from lizard fish protein hydrolysates with magnetic affinity separation","volume":"182","author":"Lan","year":"2015","journal-title":"Food Chem."},{"key":"B81","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1124\/pharmrev.120.000236","article-title":"Kidney angiotensin in cardiovascular disease: Formation and drug targeting","volume":"74","author":"Lin","year":"2022","journal-title":"Pharmacol. Rev."},{"key":"B82","doi-asserted-by":"publisher","first-page":"3221","DOI":"10.1021\/acs.jafc.8b00313","article-title":"Quantitative structure\u2013activity relationship modeling coupled with molecular docking analysis in screening of angiotensin I-converting enzyme inhibitory peptides from qula casein hydrolysates obtained by two-enzyme combination hydrolysis","volume":"66","author":"Lin","year":"2018","journal-title":"J. Agric. Food Chem."},{"key":"B83","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.jare.2020.05.007","article-title":"Hydrogen sulfide and vascular regulation \u2013 an update","volume":"27","author":"Lv","year":"2021","journal-title":"J. Adv. Res."},{"key":"B84","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.ejvs.2021.09.032","article-title":"Hydrogen sulphide release via the angiotensin converting enzyme inhibitor zofenopril prevents intimal hyperplasia in human vein segments and in a mouse model of carotid artery stenosis","volume":"63","author":"Macabrey","year":"2021","journal-title":"Eur. J. Vasc. Endovascular Surg."},{"key":"B85","doi-asserted-by":"publisher","first-page":"335","DOI":"10.4103\/pm.pm_325_17","article-title":"Angiotensin-converting enzyme inhibitory activity of Senna garrettiana active compounds: Potential markers for standardized herbal medicines","volume":"14","author":"Madaka","year":"2018","journal-title":"Pharmacogn. Mag."},{"key":"B86","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1038\/mt.2015.92","article-title":"ACE2 therapy using adeno-associated viral vector inhibits liver fibrosis in mice","volume":"23","author":"Mak","year":"2015","journal-title":"Mol. Ther."},{"key":"B87","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1097\/00004872-200110000-00023","article-title":"A random comparison of fosinopril and nifedipine GITS in patients with primary renal disease","volume":"19","author":"Marin","year":"2001","journal-title":"J. Hypertens."},{"key":"B88","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1080\/10408398.2017.1402750","article-title":"Effects of natural peptides from food proteins on angiotensin converting enzyme activity and hypertension","volume":"59","author":"Martin","year":"2019","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"B89","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1111\/febs.12660","article-title":"Crystal structures of highly specific phosphinic tripeptide enantiomers in complex with the angiotensin\u2010 I converting enzyme","volume":"281","author":"Masuyer","year":"2014","journal-title":"FEBS J."},{"key":"B90","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/srep00717","article-title":"Molecular recognition and regulation of human angiotensin-I converting enzyme (ACE) activity by natural inhibitory peptides","volume":"2","author":"Masuyer","year":"2012","journal-title":"Sci. Rep."},{"key":"B91","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1016\/j.hrthm.2015.06.007","article-title":"Association of pretreatment with angiotensin-converting enzyme inhibitors with improvement in ablation outcome in atrial fibrillation patients with low left ventricular ejection fraction","volume":"12","author":"Mohanty","year":"2015","journal-title":"Heart rhythm."},{"key":"B92","doi-asserted-by":"publisher","first-page":"6009","DOI":"10.3390\/ijms22116009","article-title":"Regulation of monocytes\/macrophages by the renin\u2013angiotensin system in diabetic nephropathy: State of the art and results of a pilot study","volume":"22","author":"Moratal","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B93","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jdcr.2021.02.018","article-title":"Oral angiotensin-converting enzyme inhibitors for treatment of delayed inflammatory reaction to dermal hyaluronic acid fillers following COVID-19 vaccination-a model for inhibition of angiotensin II\u2013induced cutaneous inflammation","volume":"10","author":"Munavalli","year":"2021","journal-title":"JAAD Case Rep."},{"key":"B94","doi-asserted-by":"publisher","first-page":"19605","DOI":"10.1038\/s41598-021-99124-z","article-title":"Critical timing of ACEi initiation prevents compensatory glomerular hypertrophy in the remaining single kidney","volume":"11","author":"Naik","year":"2021","journal-title":"Sci. Rep."},{"key":"B95","doi-asserted-by":"publisher","first-page":"8718","DOI":"10.1021\/bi049480n","article-title":"Structural details on the binding of antihypertensive drugs captopril and enalaprilat to human testicular angiotensin I-converting enzyme","volume":"43","author":"Natesh","year":"2004","journal-title":"Biochemistry"},{"key":"B96","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/nature01370","article-title":"Crystal structure of the human angiotensin-converting enzyme\u2013lisinopril complex","volume":"421","author":"Natesh","year":"2003","journal-title":"Nature"},{"key":"B97","doi-asserted-by":"publisher","first-page":"200","DOI":"10.2165\/00002018-199615030-00005","article-title":"ACE inhibitors and the kidney. A risk-benefit assessment","volume":"15","author":"Navis","year":"1996","journal-title":"Drug Saf."},{"key":"B98","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s40292-018-0252-5","article-title":"The role of renin-angiotensin-aldosterone system and its new components in arterial stiffness and vascular aging","volume":"25","author":"Neves","year":"2018","journal-title":"High. Blood Press. Cardiovasc. Prev."},{"key":"B99","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.ahj.2020.10.059","article-title":"Randomized evaluation of beta blocker and ACE-inhibitor\/angiotensin receptor blocker treatment in patients with myocardial infarction with non-obstructive coronary arteries (MINOCA-BAT): Rationale and design","volume":"231","author":"Nordenskj\u00f6ld","year":"2021","journal-title":"Am. Heart J."},{"key":"B100","doi-asserted-by":"publisher","first-page":"e362","DOI":"10.1161\/CIR.0b013e3182742cf6","article-title":"2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction: A report of the American college of cardiology foundation\/American heart association task force on practice guidelines","volume":"127","author":"O\u2019Gara","year":"2013","journal-title":"Circulation"},{"key":"B101","doi-asserted-by":"publisher","first-page":"107750","DOI":"10.1016\/j.pharmthera.2020.107750","article-title":"A comprehensive guide to the pharmacologic regulation of angiotensin converting enzyme 2 (ACE2), the SARS-CoV-2 entry receptor","volume":"221","author":"Oz","year":"2021","journal-title":"Pharmacol. Ther."},{"key":"B102","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1007\/s00384-019-03379-y","article-title":"Angiotensin I-converting enzyme inhibitors\/angiotensin II receptor blockers may reduce tumor recurrence in left-sided and early colorectal cancers","volume":"34","author":"Ozawa","year":"2019","journal-title":"Int. J. Colorectal Dis."},{"key":"B103","doi-asserted-by":"publisher","first-page":"220","DOI":"10.2174\/138161212799040547","article-title":"Enkephalin degrading enzymes: Metalloproteases with high potential for drug development","volume":"18","author":"Pal Khaket","year":"2012","journal-title":"Curr. Pharm. Des."},{"key":"B104","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1016\/j.tetasy.2011.09.013","article-title":"Advances in the chemistry of proline and its derivatives: An excellent amino acid with versatile applications in asymmetric synthesis","volume":"22","author":"Panday","year":"2011","journal-title":"Tetrahedron Asymmetry"},{"key":"B105","first-page":"55","article-title":"Effect of angiotensin-converting enzyme inhibitor on collagenolytic enzyme activity in patients with acute myocardial infarction","volume":"30","author":"Papadopoulos","year":"2004","journal-title":"Drugs Exp. Clin. Res."},{"key":"B106","first-page":"152","article-title":"Clinical significance of matrix metalloproteinases activity in acute myocardial infarction","volume":"16","author":"Papadopoulos","year":"2005","journal-title":"Eur. Cytokine Netw."},{"key":"B107","doi-asserted-by":"publisher","first-page":"107527","DOI":"10.1016\/j.pharmthera.2020.107527","article-title":"Evaluating the benefits of renin-angiotensin system inhibitors as cancer treatments","volume":"211","author":"Perini","year":"2020","journal-title":"Pharmacol. Ther."},{"key":"B108","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.ihj.2020.08.007","article-title":"ACEI-induced cough: A review of current evidence and its practical implications for optimal CV risk reduction","volume":"72","author":"Pinto","year":"2020","journal-title":"Indian Heart J."},{"key":"B109","doi-asserted-by":"publisher","first-page":"574","DOI":"10.2174\/1573406415666190514081132","article-title":"Advances in structural biology of ACE and development of domain selective ACE-inhibitors","volume":"15","author":"Polakovi\u010dov\u00e1","year":"2019","journal-title":"Med. Chem."},{"key":"B110","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","article-title":"2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur. Heart J."},{"key":"B111","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.3390\/molecules24142541","article-title":"Marine organisms as potential sources of bioactive peptides that inhibit the activity of angiotensin I-converting enzyme: A review","volume":"24","author":"Pujiastuti","year":"2019","journal-title":"Molecules"},{"key":"B112","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1517\/14656566.2013.748037","article-title":"Efficacy of combination therapy with angiotensin-converting enzyme inhibitor and calcium channel blocker in hypertension","volume":"14","author":"Red\u00f3n","year":"2013","journal-title":"Expert Opin. Pharmacother."},{"key":"B113","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.comptc.2015.03.025","article-title":"Molecular structure and acidity of captopril, zofenopril and their metabolites captopril disulfide and zofenoprilat","volume":"1062","author":"Remko","year":"2015","journal-title":"Comput. Theor. Chem."},{"key":"B114","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s11886-020-01291-4","article-title":"Outcomes in patients with COVID-19 infection taking ACEI\/ARB","volume":"22","author":"Rico-Mesa","year":"2020","journal-title":"Curr. Cardiol. Rep."},{"key":"B115","doi-asserted-by":"publisher","first-page":"2734","DOI":"10.3390\/cancers13112734","article-title":"Captopril, a renin-angiotensin system inhibitor, attenuates features of tumor invasion and down-regulates C-myc expression in a mouse model of colorectal cancer liver metastasis","volume":"13","author":"Riddiough","year":"2021","journal-title":"Cancers"},{"key":"B116","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1080\/13880209.2017.1307421","article-title":"Selection of chemical markers for the quality control of medicinal plants of the genus Cecropia","volume":"55","author":"Rivera-Mondrag\u00f3n","year":"2017","journal-title":"Pharm. Biol."},{"key":"B117","doi-asserted-by":"publisher","first-page":"4597","DOI":"10.21873\/anticanres.13639","article-title":"Renin-angiotensin inhibition in combating malignancy: A review","volume":"39","author":"Rosenthal","year":"2019","journal-title":"Anticancer Res."},{"key":"B118","doi-asserted-by":"publisher","first-page":"800","DOI":"10.2165\/00003495-199040060-00004","article-title":"Newer ACE inhibitors. A look at the future","volume":"40","author":"Salvetti","year":"1990","journal-title":"Drugs"},{"key":"B119","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1530\/JOE-12-0341","article-title":"Angiotensin-converting enzyme 2, angiotensin-(1-7) and mas: New players of the renin-angiotensin system","volume":"216","author":"Santos","year":"2013","journal-title":"J. Endocrinol."},{"key":"B120","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1152\/physrev.00023.2016","article-title":"The ACE2\/angiotensin-(1-7)\/MAS Axis of the renin-angiotensin system: Focus on angiotensin-(1-7)","volume":"98","author":"Santos","year":"2018","journal-title":"Physiol. Rev."},{"key":"B121","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1021\/acs.jcim.6b00524","article-title":"The dynamic nonprime binding of sampatrilat to the C-domain of angiotensin-converting enzyme","volume":"56","author":"Sharma","year":"2016","journal-title":"J. Chem. Inf. Model."},{"key":"B122","doi-asserted-by":"publisher","first-page":"5488","DOI":"10.1021\/acs.jmedchem.0c00441","article-title":"Molecular basis for omapatrilat and sampatrilat binding to neprilysin-implications for dual inhibitor design with angiotensin-converting enzyme","volume":"63","author":"Sharma","year":"2020","journal-title":"J. Med. Chem."},{"key":"B123","doi-asserted-by":"publisher","first-page":"420","DOI":"10.2165\/00003088-199120050-00006","article-title":"Comparison of the steady-state pharmacokinetics of fosinopril, lisinopril and enalapril in patients with chronic renal insufficiency","volume":"20","author":"Sica","year":"1991","journal-title":"Clin. Pharmacokinet."},{"key":"B124","doi-asserted-by":"publisher","first-page":"703661","DOI":"10.3389\/fmed.2021.703661","article-title":"Mortality and severity in COVID-19 patients on ACEIs and ARBs-A systematic review, meta-analysis, and meta-regression analysis","volume":"8","author":"Singh","year":"2021","journal-title":"Front. Med."},{"key":"B125","doi-asserted-by":"publisher","first-page":"m4080","DOI":"10.1136\/bmj.m4080","article-title":"First line drug treatment for hypertension and reductions in blood pressure according to age and ethnicity: Cohort study in UK primary care","volume":"371","author":"Sinnott","year":"2020","journal-title":"BMJ"},{"key":"B126","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1097\/00005344-199200209-00003","article-title":"Bradykinin-degrading enzymes: Structure, function, distribution, and potential roles in cardiovascular pharmacology","volume":"20","author":"Skidgel","year":"1992","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"B127","doi-asserted-by":"publisher","first-page":"4831","DOI":"10.1021\/bi052591h","article-title":"Inhibitory antibodies to human angiotensin-converting enzyme: Fine epitope mapping and mechanism of action","volume":"45","author":"Skirgello","year":"2006","journal-title":"Biochemistry"},{"key":"B128","first-page":"33851w","article-title":"Primary examiner-donald G. Daus assistant examiner-mark L. Berch attorney, agent, or firm-lawrence S. Levinson; merle J. Smith","volume":"77","author":"Smith","year":"1972","journal-title":"Chem. Abs."},{"key":"B129","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1002\/cpt.1863","article-title":"Risks of ACE inhibitor and ARB usage in COVID-19: Evaluating the evidence","volume":"108","author":"Sriram","year":"2020","journal-title":"Clin. Pharmacol. Ther."},{"key":"B130","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1097\/01.tp.0000131148.78203.b7","article-title":"Beneficial effects of quinaprilat on coronary vasomotor function, endothelial oxidative stress, and endothelin activation after human heart transplantation","volume":"77","author":"Steinhauff","year":"2004","journal-title":"Transplantation"},{"key":"B131","doi-asserted-by":"publisher","first-page":"3081","DOI":"10.1681\/ASN.2004080634","article-title":"Antihypertensive agents for primary prevention of diabetic nephropathy","volume":"16","author":"Strippoli","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"key":"B132","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1080\/10408440591007160","article-title":"Mode of action: Angiotensin-converting enzyme inhibition--developmental effects associated with exposure to ACE inhibitors","volume":"35","author":"Tabacova","year":"2005","journal-title":"Crit. Rev. Toxicol."},{"key":"B133","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1053\/j.gastro.2020.05.034","article-title":"Associations between angiotensin-converting enzyme inhibitors and angiotensin II receptor blocker use, gastrointestinal symptoms, and mortality among patients with COVID-19","volume":"159","author":"Tan","year":"2020","journal-title":"Gastroenterology"},{"key":"B134","doi-asserted-by":"publisher","first-page":"4239","DOI":"10.1111\/bph.14489","article-title":"Angiotensin-converting enzyme inhibitor works as a scar formation inhibitor by down-regulating Smad and TGF-\u03b2-activated kinase 1 (TAK1) pathways in mice: ACEI for scar formation","volume":"175","author":"Tan","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"B135","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1016\/0002-9149(92)90708-7","article-title":"Effect of quinapril on blood pressure and heart rate in congestive heart failure","volume":"69","author":"Townend","year":"1992","journal-title":"Am. J. Cardiol."},{"key":"B136","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.3389\/fimmu.2020.01919","article-title":"Inhibition of angiotensin converting enzyme impairs anti-staphylococcal immune function in a preclinical model of implant infection","volume":"11","author":"Trikha","year":"2020","journal-title":"Front. Immunol."},{"key":"B137","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/s41587-020-00796-1","article-title":"Hypertension delays viral clearance and exacerbates airway hyperinflammation in patients with COVID-19","volume":"39","author":"Trump","year":"2021","journal-title":"Nat. Biotechnol."},{"key":"B138","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.foodchem.2018.02.107","article-title":"Identification of a novel ACE-inhibitory peptide from casein and evaluation of the inhibitory mechanisms","volume":"256","author":"Tu","year":"2018","journal-title":"Food Chem."},{"key":"B139","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/s0165-6147(00)01994-5","article-title":"The angiotensin\u2013converting enzyme gene family: Genomics and pharmacology","volume":"23","author":"Turner","year":"2002","journal-title":"Trends Pharmacol. Sci."},{"key":"B140","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1093\/protein\/gzg122","article-title":"Structure-function discrimination of the N- and C- catalytic domains of human angiotensin-converting enzyme: Implications for Cl- activation and peptide hydrolysis mechanisms","volume":"16","author":"Tzakos","year":"2003","journal-title":"Protein Eng."},{"key":"B141","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1002\/cbic.200400386","article-title":"Domain-selective ligand-binding modes and atomic level pharmacophore refinement in angiotensin I converting enzyme (ACE) inhibitors","volume":"6","author":"Tzakos","year":"2005","journal-title":"Chembiochem."},{"key":"B142","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1111\/odi.13655","article-title":"Influence of different anti-hypertensive drugs on gingival overgrowth: A cross\u2010sectional study in a Turkish population","volume":"27","author":"Ustao\u011flu","year":"2021","journal-title":"Oral Dis."},{"key":"B143","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1161\/01.HYP.0000151323.93372.f5","article-title":"Selective angiotensin-converting enzyme C-domain inhibition is sufficient to prevent angiotensin I\u2013induced vasoconstriction","volume":"45","author":"van Esch","year":"2005","journal-title":"Hypertension"},{"key":"B144","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1161\/CIRCRESAHA.117.311402","article-title":"Hypertension and atrial fibrillation: Doubts and certainties from basic and clinical studies","volume":"122","author":"Verdecchia","year":"2018","journal-title":"Circ. Res."},{"key":"B145","doi-asserted-by":"publisher","first-page":"107628","DOI":"10.1016\/j.pharmthera.2020.107628","article-title":"Good or bad: Application of RAAS inhibitors in COVID-19 patients with cardiovascular comorbidities","volume":"215","author":"Wang","year":"2020","journal-title":"Pharmacol. Ther."},{"key":"B146","doi-asserted-by":"publisher","first-page":"7967","DOI":"10.1039\/c9fo02127b","article-title":"Angiotensin-converting enzyme inhibiting ability of ethanol extracts, steviol glycosides and protein hydrolysates from stevia leaves","volume":"10","author":"Wang","year":"2019","journal-title":"Food Funct."},{"key":"B147","doi-asserted-by":"publisher","first-page":"3137","DOI":"10.1042\/CS20201268","article-title":"ACE2: From protection of liver disease to propagation of COVID-19","volume":"134","author":"Warner","year":"2020","journal-title":"Clin. Sci."},{"key":"B148","doi-asserted-by":"publisher","first-page":"9002","DOI":"10.1016\/s0021-9258(18)31543-6","article-title":"The two homologous domains of human angiotensin I-converting enzyme are both catalytically active","volume":"266","author":"Wei","year":"1991","journal-title":"J. Biol. Chem."},{"key":"B149","doi-asserted-by":"publisher","first-page":"13398","DOI":"10.1016\/s0021-9258(18)42224-7","article-title":"The two homologous domains of human angiotensin I-converting enzyme interact differently with competitive inhibitors","volume":"267","author":"Wei","year":"1992","journal-title":"J. Biol. Chem."},{"key":"B150","doi-asserted-by":"publisher","first-page":"531","DOI":"10.2215\/CJN.07821109","article-title":"Potassium homeostasis and renin-angiotensin-aldosterone system inhibitors","volume":"5","author":"Weir","year":"2010","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"B151","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/s0006-291x(84)80337-x","article-title":"Design of conformationally constrained angiotensin-converting enzyme inhibitors","volume":"125","author":"Weller","year":"1984","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B152","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1042\/bj3180125","article-title":"Drosophila melanogaster angiotensin I-converting enzyme expressed in Pichia pastoris resembles the C domain of the mammalian homologue and does not require glycosylation for secretion and enzymic activity","volume":"318","author":"Williams","year":"1996","journal-title":"Biochem. J."},{"key":"B153","doi-asserted-by":"publisher","first-page":"112724","DOI":"10.1016\/j.jep.2020.112724","article-title":"Anti-hypertensive and angiotensin-converting enzyme inhibitory effects of Radix Astragali and its bioactive peptide AM-1","volume":"254","author":"Wu","year":"2020","journal-title":"J. Ethnopharmacol."},{"key":"B154","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1136\/heartjnl-2020-316823","article-title":"Long-term survival benefit of ramipril in patients with acute myocardial infarction complicated by heart failure","volume":"107","author":"Wu","year":"","journal-title":"Heart"},{"key":"B155","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1080\/07388551.2021.1948816","article-title":"Angiotensin I-converting enzyme inhibitory peptide: An emerging candidate for vascular dysfunction therapy","volume":"42","author":"Wu","year":"","journal-title":"Crit. Rev. Biotechnol."},{"key":"B156","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1080\/07388551.2021.1948816","article-title":"Angiotensin I-converting enzyme inhibitory peptide: An emerging candidate for vascular dysfunction therapy","volume":"42","author":"Wu","year":"2022","journal-title":"Crit. Rev. Biotechnol."},{"key":"B157","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.jff.2014.12.051","article-title":"Purification and identification of Angiotensin-I Converting Enzyme (ACE) inhibitory peptide from lizard fish (Saurida elongata) hydrolysate","volume":"13","author":"Wu","year":"2015","journal-title":"J. Funct. Foods"},{"key":"B158","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ejphar.2016.12.031","article-title":"Unknown face of known drugs \u2013 what else can we expect from angiotensin converting enzyme inhibitors?","volume":"797","author":"Wzgarda","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"B159","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.fitote.2016.12.001","article-title":"Megastigmane glycosides from leaves of Eucommia ulmoides Oliver with ACE inhibitory activity","volume":"116","author":"Yan","year":"2017","journal-title":"Fitoterapia"},{"key":"B160","doi-asserted-by":"publisher","first-page":"e137","DOI":"10.1161\/CIR.0000000000000509","article-title":"2017 ACC\/AHA\/HFSA focused update of the 2013 ACCF\/AHA guideline for the management of heart failure: A report of the American college of cardiology\/American heart association task force on clinical practice guidelines and the heart failure society of America","volume":"136","author":"Yancy","year":"2017","journal-title":"Circulation"},{"key":"B161","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1161\/HYPERTENSIONAHA.120.15143","article-title":"Effects of angiotensin II receptor blockers and ACE (Angiotensin-Converting enzyme) inhibitors on virus infection, inflammatory status, and clinical outcomes in patients with COVID-19 and hypertension: A single-center retrospective study","volume":"76","author":"Yang","year":"","journal-title":"Hypertension"},{"key":"B162","first-page":"884","article-title":"The role of the renin-angiotensin system inhibitors in malignancy: A review","volume":"11","author":"Yang","year":"2021","journal-title":"Am. J. Cancer Res."},{"key":"B163","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/s41419-020-2675-x","article-title":"Enalapril overcomes chemoresistance and potentiates antitumor efficacy of 5-FU in colorectal cancer by suppressing proliferation, angiogenesis, and NF-\u03baB\/STAT3-regulated proteins","volume":"11","author":"Yang","year":"","journal-title":"Cell Death Dis."},{"key":"B164","doi-asserted-by":"publisher","first-page":"e20674","DOI":"10.1097\/MD.0000000000020674","article-title":"The efficacy of angiotensin converting enzyme inhibitors versus angiotensin II receptor blockers on insulin resistance in hypertensive patients: A protocol for a systematic review and meta-analysis","volume":"99","author":"Yao","year":"2020","journal-title":"Medicine"},{"key":"B165","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1161\/CIRCRESAHA.120.317134","article-title":"Association of inpatient use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19","volume":"126","author":"Zhang","year":"","journal-title":"Circ. Res."},{"key":"B166","doi-asserted-by":"publisher","first-page":"104927","DOI":"10.1016\/j.phrs.2020.104927","article-title":"ACEI\/ARB use and risk of infection or severity or mortality of COVID-19: A systematic review and meta-analysis","volume":"158","author":"Zhang","year":"","journal-title":"Pharmacol. Res."},{"key":"B167","doi-asserted-by":"publisher","first-page":"113613","DOI":"10.1016\/j.lwt.2022.113613","article-title":"In vitro gastrointestinal digestion study and identification of novel angiotensin i-converting enzyme inhibitory peptide from broccoli (brassica oleracea)","volume":"164","author":"Zhang","year":"2022","journal-title":"LWT"},{"key":"B168","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s12967-020-02314-y","article-title":"Real-world use of ACEI\/ARB in diabetic hypertensive patients before the initial diagnosis of obstructive coronary artery disease: Patient characteristics and long-term follow-up outcome","volume":"18","author":"Zhang","year":"","journal-title":"J. Transl. Med."},{"key":"B169","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/s1872-2075(08)60007-2","article-title":"Structure and function of angiotensin converting enzyme and its inhibitors","volume":"24","author":"Zhao","year":"2008","journal-title":"Chin. J. Biotechnol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.968104\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T07:03:54Z","timestamp":1667286234000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.968104\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,1]]},"references-count":169,"alternative-id":["10.3389\/fphar.2022.968104"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2022.968104","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,1]]},"article-number":"968104"}}